Insulin and glucagon secretion in hepatic glycogenoses.
Insulin and glucagon secretion was investigated in ten patients with hepatic glycogenosis, types I and III, in order to understand the relationship between hypoglycemia and pancreatic function. In all patients, both oral glucose tolerance and intravenous arginine infusion tests revealed hypoinsulinemia. Decreased urinary C-peptide levels with standard food intake also supported hypofunction of pancreatic beta cells. On the contrary, the normal secretion pattern of glucagon in both types indicated in the arginine loading test, intact alpha cells in the pancreas. Persistent hypoinsulinism, which is apparently an adaptation to hypoglycemia, could be an important cause of nutritional dwarfism in both types of glycogenosis. The usefulness of the measurement of urinary C-peptide, which evaluates the pancreatic function and provides management for normal body growth, is discussed.
D001786:Blood Glucose / Q000032:analysis; D002096:C-Peptide / Q000652:urine; D002648:Child; D002675:Child, Preschool; D005260:Female; D005934:Glucagon / Q000097:blood / Q000378:metabolism*; D005951:Glucose Tolerance Test; D006008:Glycogen Storage Disease / Q000503:physiopathology*; D005953:Glycogen Storage Disease Type I / Q000503:physiopathology*; D006010:Glycogen Storage Disease Type III / Q000503:physiopathology*; D006801:Humans; D007223:Infant; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D000078790:Insulin Secretion; D008297:Male
D001786:Blood Glucose; D002096:C-Peptide; D007328:Insulin; D005934:Glucagon